European Psychiatry - Volume 41 - April 2017

43 / 916

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S8–S52 S39
cal & public health concern: The European Union’s CAMHEE report
recommends better information on CAPRI risks and resilience and
to enable interventions to target the highest risk. This is important
because although large numbers of children are in the riskset, most
remain resilient. Research needs to support delivery of the CAMHEE
initiative by understanding who is at risk and how we can target
them early before their life trajectories are fatally disrupted.
To do this, we aimto create groundbreaking cross- national datasets
providing robust data on CAPRI prevalence & life trajectories
needed to plan future services.
But epidemiology alone cannot expose how risk creates effects at
the individual level. We need to know which CAPRI to target with
potentially expensive, time-consuming specialist services
Powerful neuroscience techniques such as functional near infrared
spectroscopy are now available with which we can link epidemio-
logical risk to elucidate effects of exposure within individual infant
brain. This unique interdisciplinary approach yokes robust epi-
demiological evidence to cutting-edge optical imaging that can be
undertaken in very young infants.
This allows us to target developments in clinical interventions for
CAPRI to those in greatest need and potentially to those most
vulnerable with the future aim to identify early biomarkers of
abnormality for targeting intervention in CAPRI.
Disclosure of interest The author declares that he has no compet-
ing interest.
Symposium: diagnostic tools and medical device
technologies in psychiatry
S104
Big data market analysis of e-health in
medical neuroscience
A. Stellbrink ∗ eisenzahl
Kliniken der Heinrich-Heine-universität Düsseldorf, klinik und
poliklinik für psychiatrie und psychotherapie, Düsseldorf, Germany
∗ Corresponding author.
Depression is associated with more than 100,000 patent applica-
tions for its diagnosis and prognosis, the highest number among
mental disorders. This is followed by schizophrenia with 47,000,
bipolar disorder with 32,110 and hypomania with 11,377. Among
diagnostic tools, magnetic resonance imaging is associated with
more than 31,000 patent applications. Among recent technologies,
biomarkers are associated with more than 12,000 epigenetics with
about 970 metabolomics with 515 genome-wide association study
(GWAS) with 486 and bionics with 497 patent applications. The
patent applications related to diagnosis and prognosis of psychi-
atric diseases peaked in 2008 andwas overall decreasing until 2016,
with a local peak in 2013. This trend has been observed despite
the value addition of recent technologies like machine learning, big
data and internet of things. However, more conservative diagnostic
tools from the last decade like magnetic resonance imaging, epige-
netics, bionics and neuro-psychological testing are improved by the
recent technologies. For example, bionics is improved by sensors of
internet of things to collect the data frompatients around theworld
and use the big data analytics to efficiently diagnose the psychiatric
diseases. The Regents of the University of California and Human
Genome Sciences Incorporation are the respective academic and
non-academic institutions leading the innovations related to diag-
nosis and prognosis of psychiatric diseases.
Disclosure of interest The authors declare that they have no com-
peting interest.
S105
The ethics of mobile health
technology
S. Galderisi∗, F. Caputo
University of Campania “Luigi Vanvitelli”, department of psychiatry,
Naples, Italy
∗ Corresponding author.
Introduction Mobile health (m-health) technology has been
growing rapidly in the last decades. The use of this technology
represents an advantage, especially for reaching patients who oth-
erwise would have no access to healthcare. However, many ethical
issues arise from the use of m-health. Health equity, privacy poli-
cies, adequate informed consent and a competent, safe and high
quality healthcare need to be guaranteed; professional standards
and quality of doctor-patient relationship in the digital setting
should not be lower than those set for in-person practice.
Aims To assess advantages and threats that may arise from the
wide use of m-health technologies, in order to guarantee the appli-
cation of the best medical practices, resulting in the highest quality
healthcare.
Methods A literature search has been conducted to highlight the
most pressing ethical issues emerging from the spreading of m-
health technologies.
Results Fewethical guidelines on the appropriate use ofm-health
have been developed to help clinicians adopt a professional con-
duct within digital settings. They focus on the need for professional
associations to define ethical guidelines and for physicians to take
care of their education and online behavior when using m-health
technologies.
Conclusions The rapid spreading of m-health technologies urges
us to evaluate all ethical issues related to its use. It would be
advisable to produce an ethical code for the use of these new
technologies, to guarantee health equity, privacy protection, high
quality doctor-patient relationships and to ensure that m-health is
not chosen over traditional care for merely economic purposes.
Disclosure of interest SG received honoraria or Advisory
board/consulting fees from the following companies: Lund-
beck, Janssen Pharmaceuticals, Hoffman-La Roche, Angelini-Acraf,
Otsuka, Pierre Fabre and Gedeon-Richter. All other authors have
declared.
Symposium: Social cognition in schizophrenia:
pathophysiology, functional implications and
treatment options
S106
Disorganization and social cognition:
Data from the italian network of
research on psychoses
P. Rocca
Unito, Italy
Social cognition (SC) refers broadly to the domains of cognitive
functions that are employed in socially relevant situations. These
disturbances have been found to be strongly related to disor-
ganized and negative symptoms in schizophrenia. Each of the
disorganization symptoms suggests a diminishment or absence
of organization. There seems to be a loss of the ability to be
directed toward or committed to a particular focal topic or goal.
Such conditions are likely to impact patients’ drives or motiva-
tions to initiate goal-directed activities that could yield pleasurable
opportunities. Moreover, it has been suggested that disorganized